Similar articles

• Bell's palsy after onset of insulin-like growth factor I therapy in a patient with growth hormone receptor deficiency.

  Wollmann HA, Ranke MB. Wollmann HA, et al. Acta Paediatr Suppl. 1994 Apr;399:148-9. doi: 10.1111/j.1651-2227.1994.tb13312.x. Acta Paediatr Suppl. 1994. PMID: 7949603 No abstract available.
• Transient bilateral papilloedema in a 10-year-old boy treated with recombinant insulin-like growth factor I for growth hormone receptor deficiency.

  Lordereau-Richard I, Roger M, Chaussain JL. Lordereau-Richard I, et al. Acta Paediatr Suppl. 1994 Apr;399:152. doi: 10.1111/j.1651-2227.1994.tb13314.x. Acta Paediatr Suppl. 1994. PMID: 7949605 No abstract available.
• Growth hormone receptor deficiency in Ecuador.

  Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Francke U. Rosenbloom AL, et al. J Clin Endocrinol Metab. 1999 Dec;84(12):4436-43. doi: 10.1210/jcem.84.12.6283. J Clin Endocrinol Metab. 1999. PMID: 10599699 Review. No abstract available.
• Möbius syndrome: clinico-radiologic correlation.

  Kim N, Kim JH, Kim JS, Hwang JM. Kim N, et al. Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2219-2223. doi: 10.1007/s00417-018-4089-3. Epub 2018 Aug 1. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 30069750
• Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.

  Carel JC, Chaussain JL, Chatelain P, Savage MO. Carel JC, et al. Diabetes Metab. 1996 Jul;22(4):251-6. Diabetes Metab. 1996. PMID: 8767171 Review.